Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant Lymphomas

New England Journal of Medicine

Volumn 317, Issue 19, 1987, Pages 1185-1189

  Weiss, Lawrence M ^a   Warnke, Roger A ^a   Sklar, Jeffrey ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; CHROMOSOME TRANSLOCATION; DIAGNOSIS; GENETIC ENGINEERING; HEREDITY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY;

EID: 0023275274     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198711053171904     Document Type: Article

References (31)

1. Yunis JJ, Oken MM, Kaplan ME, et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982; 307: 1231–6.
2. Yunis JJ, Oken MM, Theologides A, Howe RB, Kaplan ME. Recurrent chromosomal defects are found in most patients with non-Hodgkin's lymphoma. Cancer Genet Cytogenet 1984; 13: 17–28.
3. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ. Nonrandom chromosome abnormalities in lvmphoma. Cancer Res 1983; 43: 2975–84.
4. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 1985; 66: 1414–22.
5. Koduru PR, Filippa DA, Richardson ME, et al. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987; 69: 97–102.
6. Fukuhara S, Rowley JD, Variakojis D, Golomb HM. Chromosomal abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 1979; 39: 3119–28.
7. Geary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82: 7439–43.
8. Bakhshi A, Jensen JP, Goldman J, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906.
9. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390–3.
10. Geary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;l8) translocation. Cell 1986; 47: 19–28.
11. Cleary ML, Galili N, Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 1986; 164: 315–20.
12. Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H. Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer 1981; 48: 1415–25.
13. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer 1982; 49: 1429–38.
14. Lennert K. Malignant lymphomas. New York: Springer-Verlag, 1978.
15. Weiss LM, Strickler JG, Hu E, Warnke RA, Sklar J. Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol 1986; 17: 1009–14.
16. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26: 1063–83.
17. Cleary ML, Chao J, Warnke R, Sklar J. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci USA 1984; 81: 593–7.
18. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–17.
19. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific affinity. Anal Biochem 1983; 132: 6–13.
20. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–3.
21. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M. Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med 1987; 316: 79–84.
22. Hubbard SM, Chabner BA, De Vita VT Jr, et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258–64.
23. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11–16.
24. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lvmphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35.
25. Harris NL, Nadler LM, Bhan AK. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies: follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities. Am J Pathol 1984; 117: 262–72.
26. Lukes RJ, Collins RD. Immunological characterization of human malignant lymphomas. Cancer 1974; 34: 1488–503.
27. Mann RB, Jaffe ES, Berard CW. Malignant lymphomas — a conceptual understanding of morphologic diversity. Am J Pathol 1979; 94: 105–92.
28. Timens W, Visser L, Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest 1986; 54: 457–61.
29. Lenoir GM, Preud'homme JL, Bernheim A, Berger R. Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature 1982; 298: 474–6.
30. Pelicci P-G, Knowles DM 2nd, Dalla Favera R. Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes. J Exp Med 1985; 162: 1015–24.
31. Finan J, Daniele R, Rowlands D, Nowell P. Cytogenetics of chronic T cell leukemia, including two patients with a 14q+ translocation. Virchows Arch [Cell Pathol] 1978; 29: 121–7.